Neonatal Fc Receptor Blockers [MoA] - N0000194005
Pharmacologic Class Information
| Pharmacologic Code | N0000194005 |
| Pharmacologic Name | Neonatal Fc Receptor Blockers |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Neonatal Fc Receptor Blockers
The table contains 2 products whose active ingredient are classified under the same pharmacologic class Neonatal Fc Receptor Blockers [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 73475-3041 | Vyvgart | Non-Proprietary Name: Efgartigimod Alfa | Injection | Intravenous | Argenx Us | ACTIVE | |
| 73475-3102 | Vyvgart Hytrulo | Non-Proprietary Name: Efgartigimod Alfa And Hyaluronidase (human Recombinant) | Injection, Solution | Subcutaneous | Argenx Us | ACTIVE |